Vedolizumab as the first line of biologic therapy for ulcerative colitis and Crohn's disease – a systematic review with meta-analysis - Digestive and Liver Disease
Book Preview: Notable authors' fall releases range from dystopian novels to autobiographies - Daily Bruin